GlassScriptPhysician profile
Liesa A Davis
NPI 1083018501
$3,484.88
in general payments reported to CMS, 2019-2025
20 companies · $1,115 in 2025
The $1,115 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $225 · 2022: $579 · 2023: $643 · 2024: $923 · 2025: $1,115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,680.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $784.78 | 2021-2025 | |
| Abbvie INC. | $677.59 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $642.15 | 2022-2025 | Dupixent |
| Glaxosmithkline, LLC. | $316.39 | 2022-2025 | Nucala |
| Genzyme Corporation | $269.96 | 2024-2025 | |
| Pfizer INC. | $193.02 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $104.87 | 2024 | Voquezna |
| Alk-Abello, INC | $77.02 | 2021-2023 | Grastek, Ragwitek, Odactra |
| Inspire Medical Systems, INC. | $57.26 | 2023-2025 | Inspire |
| Phadia US INC. | $56.04 | 2023-2025 | Immunocap |
| Amgen INC. | $48.41 | 2025 | Tezspire |
| Stryker Corporation | $43.71 | 2021-2023 | Audion Et Dilation System |
| Hikma Pharmaceuticals USA | $39.55 | 2023-2024 | Ryaltris |
| Intersect Ent, INC. | $32.88 | 2021 | |
| Ambu INC. | $32.86 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $29.09 | 2022 | |
| Paratek Pharmaceuticals, INC. | $27.55 | 2025 | Xhance |
| Vertex Pharmaceuticals Incorporated | $19.42 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $17.66 | 2023 | Seglentis |
| Kaleo, INC. | $14.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liesa Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.